Testing for STIs at home

March 31, 2025
The marketing authorization was granted to Visby Medical.

The U.S. Food and Drug Administration (FDA) has granted marketing authorization for an at home chlamydia, gonorrhea, and trichomoniasis test.

The test, Visby Medical Women’s Sexual Health Test, is manufactured by Visby Medical. According to the FDA’s announcement, the test can be acquired over-the-counter and administered at home. Women can take the test regardless of symptoms and will receive results on an app in about 30 minutes.  

Additionally, “the Visby Medical Women’s Sexual Health Test correctly identified 98.8% of negative and 97.2% of positive Chlamydia trachomatis samples, 99.1% of negative and 100% of positive Neisseria gonorrhoeae samples and 98.5% of negative and 97.8% of positive Trichomonas vaginalis samples.”

FDA release

ID 337550828 © Pratoomrat Tongkate | Dreamstime.com
dreamstime_xxl_337550828
ID 89045693 © Natal'ya Buzuevskaya | Dreamstime.com
dreamstime_xxl_89045693
matawee matipano/iStock/Getty Images Plus/Getty Images
gettyimages1176254834
Courtesy of the CDC
Sexually Transmitted Infections - United States 2024-2023.
ID 198961638 © Valiantsin Suprunovich | Dreamstime.com
dreamstime_xxl_198961638